Oxidative stress-related markers as prognostic factors for patients with primary sclerosing cholangitis in Japan

被引:1
|
作者
Oyama, Atsushi [1 ]
Takaki, Akinobu [1 ]
Adachi, Takuya [1 ]
Wada, Nozomu [1 ]
Takeuchi, Yasuto [1 ]
Onishi, Hideki [1 ]
Shiraha, Hidenori [1 ]
Okada, Hiroyuki [1 ]
Otsuka, Motoyuki [1 ]
机构
[1] Okayama Univ, Fac Med Dent & Pharmaceut Sci, Dept Gastroenterol & Hepatol, 2-5-1 Shikata cho,Kita ku, Okayama 7008558, Japan
关键词
Primary sclerosing cholangitis; Oxidative stress marker; Prognosis; Serum reactive oxygen metabolite; Total serum antioxidant capacity; Revised Mayo risk score; Child-Pugh score; MELD score; FIB-4; index; Serum dROM; Serum OXY-adsorbent test; Immunoglobulin A; AUTOANTIBODIES; AGE;
D O I
10.1007/s12072-023-10557-2
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background/purposePrimary sclerosing cholangitis (PSC) is a rare chronic liver disease. The mechanisms and prediction of PSC progression are unclear. Recent investigations have shown that general conditions, such as oxidative stress, affect the course of chronic diseases. We investigated the clinical course and oxidative stress-related condition of PSC to determine prognostic factors.MethodsWe recruited 58 patients with PSC (mean age; 37.4 years, mean observation period; 1382 days) who visited our department from 2003 to 2021. Clinical characteristics were investigated to define prognostic factors. Oxidative stress status was evaluated using two types of markers: an oxidative stress marker (serum reactive oxygen metabolite; dROM) and an antioxidant marker (serum OXY adsorbent test; OXY).ResultsThe revised Mayo risk, Child-Pugh, model for end-stage liver disease-sodium (MELD-Na) scores or fibrosis-related FIB-4 index significantly predicted poor overall survival. High intestinal immunoglobulin A (IgA) levels predicted poor survival. Among patients with high and intermediate revised Mayo risk scores, those with physiologically high dROM levels showed better survival than those with lower dROM levels. In this population, dROM was negatively correlated with AST and IgA, which are both correlated with survival.ConclusionsHigh and intermediate revised Mayo risk score group predicted a poor clinical course in PSC. Additionally, the Child-Pugh score, MELD-Na score, FIB-4 index, and serum IgA were significantly correlated with survival. In patients with high and intermediate revised Mayo risk scores, physiologically high oxidative stress status correlated with low IgA levels and a good prognosis.
引用
收藏
页码:1215 / 1224
页数:10
相关论文
共 50 条
  • [31] Natural history and prognostic models in primary sclerosing cholangitis
    Talwalkar, JA
    Lindor, KD
    BEST PRACTICE & RESEARCH CLINICAL GASTROENTEROLOGY, 2001, 15 (04) : 563 - 575
  • [32] Validation of a cholangiographic prognostic model in primary sclerosing cholangitis
    Ponsioen, C. Y.
    Reitsma, J. B.
    Boberg, K. M.
    Aabakken, L.
    Rauws, E. A. J.
    Schrumpf, E.
    ENDOSCOPY, 2010, 42 (09) : 742 - 747
  • [33] Pregnancy in patients with primary sclerosing cholangitis
    Janczewska, I
    Olsson, R
    Hultcrantz, R
    Broome, U
    LIVER, 1996, 16 (05): : 326 - 330
  • [34] Cholangiocarcinoma in patients with primary sclerosing cholangitis
    Fung, Brian M.
    Tabibian, James H.
    CURRENT OPINION IN GASTROENTEROLOGY, 2020, 36 (02) : 77 - 84
  • [35] Management of patients with primary sclerosing cholangitis
    Stiehl, A
    Benz, C
    Sauer, P
    BILE ACIDS IN HEPATOBILIARY DISEASE, 2000, 110B : 47 - 50
  • [36] SURVIVAL AND USE OF A PROGNOSTIC MODEL IN PRIMARY SCLEROSING CHOLANGITIS
    FARRANT, JM
    HAYLLAR, K
    LO, SK
    CHAPMAN, RW
    WILLIAMS, R
    GUT, 1991, 32 (10) : A1249 - A1250
  • [37] Prognostic Significance of Severe Vitamin D Deficiency in Patients with Primary Sclerosing Cholangitis
    Ebadi, Maryam
    Rider, Elora
    Tsai, Catherine
    Wang, Sarah
    Lytvyak, Ellina
    Mason, Andrew
    Montano-Loza, Aldo J.
    NUTRIENTS, 2023, 15 (03)
  • [38] Primary sclerosing cholangitis - role of nutritional factors
    Wroblewska, Edyta
    Tyszko, Piotr
    Okreglicka, Katarzyna
    FAMILY MEDICINE AND PRIMARY CARE REVIEW, 2014, 16 (04): : 378 - 381
  • [39] RISK-FACTORS IN PRIMARY SCLEROSING CHOLANGITIS
    SCHRUMPF, E
    ABDELNOOR, M
    FAUSA, O
    ELGJO, K
    JENSSEN, E
    KOLMANNSKOG, F
    JOURNAL OF HEPATOLOGY, 1994, 21 (06): : 1061 - 1066
  • [40] Factors predictive of the efficacy of bezafibrate therapy in patients with primary sclerosing cholangitis
    Mizuno, Suguru
    Isayama, Hiroyuki
    Hirano, Kenji
    Watanabe, Takeo
    Takahara, Naminatsu
    Kogure, Hirofumi
    Matsubara, Saburo
    Nakai, Yousuke
    Tada, Minoru
    Koike, Kazuhiko
    HEPATOLOGY RESEARCH, 2017, 47 (11) : 1102 - 1107